Belizatinib

Overview

Belizatinib (TSR-011) is an orally active, potent inhibitor of ALK and TRKA , TRKB , and TRKC , with IC 50 of 0.7 nM for wild-type recombinant ALK kinase.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Pain | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Signaling Pathways > Anaplastic lymphoma kinase (ALK) | Products > Signaling Pathways > Trk Receptor

Product Information

• Catalog No.: HY-17603
• CAS No.: 1357920-84-3
• Molecular Formula: C33H44FN5O3
• Molecular Weight: 577.73
• Purity: 99.62%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Availability: In-stock

Source

Original product source